AmCad BioMed Corporation (TPEX:4188)

AmCad BioMed Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	17.76	29.66	47.04	58.51	59.65
Short-Term Investments	343.95	252.61	280.78	312.54	331.47
Trading Asset Securities	4	5	3.02	-	4
Cash & Short-Term Investments	365.71	287.27	330.84	371.05	395.12
Cash Growth	27.30%	-13.17%	-10.84%	-6.09%	-12.66%
Accounts Receivable	20.66	11.35	4.51	5.78	2.76
Other Receivables	0.01	-	0.06	0.13	1.71
Receivables	20.66	11.35	4.57	5.91	4.47
Inventory	30.09	25.02	23.33	21.24	21.73
Prepaid Expenses	1.28	2.07	1.02	2.03	0.29
Other Current Assets	0.34	0.18	0.12	0.31	0.51
Total Current Assets	418.09	325.89	359.88	400.54	422.12
Property, Plant & Equipment	82.92	82.71	79.81	88.23	81
Long-Term Investments	125.68	28.06	28.74	34.47	52.44
Goodwill	31.18	31.18	31.18	31.18	31.18
Other Intangible Assets	35.15	42.5	50.54	58.62	66.76
Other Long-Term Assets	1.87	2.3	3.72	2.72	3.05
Total Assets	694.87	512.65	553.86	615.75	656.55
Accounts Payable	2.74	1.95	1.06	1.15	1.55
Current Portion of Leases	5.15	4.4	3.88	4.42	2.04
Current Unearned Revenue	0.51	2.05	2.67	5.45	32.63
Other Current Liabilities	16.75	16.02	19.75	15.11	11.5
Total Current Liabilities	25.14	24.42	27.36	26.13	47.71
Long-Term Leases	5.72	9.99	6.43	10.31	2.22
Long-Term Unearned Revenue	-	-	-	-	4.43
Other Long-Term Liabilities	0.29	0.29	0.29	0.28	7.08
Total Liabilities	31.16	34.7	34.08	36.72	61.44
Common Stock	633.33	532.56	532.21	532.21	532.21
Additional Paid-In Capital	141.52	8.02	95.74	94.92	94.38
Retained Earnings	-199.32	-148.74	-192.06	-138.57	-117.86
Comprehensive Income & Other	-6.88	-11.25	-11.32	-5.59	-11.02
Total Common Equity	568.65	380.58	424.58	482.98	497.7
Minority Interest	95.07	97.37	95.2	96.06	97.4
Shareholders' Equity	663.72	477.95	519.78	579.03	595.1
Total Liabilities & Equity	694.87	512.65	553.86	615.75	656.55
Total Debt	10.87	14.39	10.31	14.73	4.25
Net Cash (Debt)	354.84	272.88	320.53	356.32	390.87
Net Cash Growth	30.03%	-14.87%	-10.04%	-8.84%	-11.60%
Net Cash Per Share	6.15	5.13	6.02	6.70	7.35
Filing Date Shares Outstanding	63.33	53.26	53.22	53.22	53.22
Total Common Shares Outstanding	63.33	53.26	53.22	53.22	53.22
Working Capital	392.94	301.47	332.52	374.41	374.4
Book Value Per Share	8.98	7.15	7.98	9.07	9.35
Tangible Book Value	502.33	306.9	342.87	393.18	399.76
Tangible Book Value Per Share	7.93	5.76	6.44	7.39	7.51
Land	52.94	52.94	52.94	52.94	52.94
Buildings	8.14	8.14	8.14	8.14	8.14
Machinery	15.57	25.15	48.47	47.34	44.92
Leasehold Improvements	-	-	0.82	0.82	1.48

Source: S&P Global Market Intelligence. Standard template. Financial Sources.